Amy A. Wendell's most recent trade in Axogen Inc. was a trade of 20,436 Stock Option (right to purchase) done . Disclosure was reported to the exchange on Dec. 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2025 | 20,436 | 0 | - | - | Stock Option (right to purchase) | |
| Axogen Inc | Amy A. Wendell | Director | Sale of securities on an exchange or to another person at price $ 29.31 per share. | 16 Dec 2025 | 20,436 | 112,074 (0%) | 0% | 29.3 | 599,020 | Common Stock |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.30 per share. | 16 Dec 2025 | 20,436 | 119,262 (0%) | 0% | 6.3 | 128,747 | Common Stock |
| Axogen Inc | Amy A. Wendell | Director | Sale of securities on an exchange or to another person at price $ 29.31 per share. | 16 Dec 2025 | 18,248 | 93,826 (0%) | 0% | 29.3 | 534,885 | Common Stock |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.04 per share. | 16 Dec 2025 | 18,248 | 137,510 (0%) | 0% | 7.0 | 128,466 | Common Stock |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2025 | 18,248 | 0 | - | - | Stock Option (right to purchase) | |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2025 | 5,000 | 0 | - | - | Stock Option (right to purchase) | |
| Axogen Inc | Amy A. Wendell | Director | Sale of securities on an exchange or to another person at price $ 29.31 per share. | 16 Dec 2025 | 5,000 | 132,510 (0%) | 0% | 29.3 | 146,560 | Common Stock |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.95 per share. | 16 Dec 2025 | 5,000 | 98,826 (0%) | 0% | 9.0 | 44,750 | Common Stock |
| Axogen Inc | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2025 | 14,150 | 14,150 | - | - | Restricted Stock Units | |
| Axogen Inc | Amy A. Wendell | Director | Sale of securities on an exchange or to another person at price $ 10.61 per share. | 09 Jun 2025 | 4,073 | 93,826 (0%) | 0% | 10.6 | 43,215 | Common Stock |
| Solventum | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 3,564 | 3,564 | - | 0 | Common Stock | |
| Solventum | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 3,564 | 0 | - | - | Restricted Stock Units | |
| Baxter International | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 7,183 | 31,222 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Solventum | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 3,403 | 3,403 | - | - | Restricted Stock Units | |
| Axogen Inc | Amy A. Wendell | Director | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 03 Mar 2025 | 5,000 | 97,899 (0%) | 0% | 20.0 | 100,100 | Common Stock |
| Hologic | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 5,535 | 5,535 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 1,864 | 22,594 (0%) | 0% | - | Common Stock | |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 11,904 | 102,899 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 11,904 | 0 | - | - | Restricted Stock Units | |
| Axogen Inc | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 18,248 | 18,248 | - | - | Stock Option (right to purchase) | |
| Axogen Inc | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 10,653 | 90,995 (0%) | 0% | - | Common Stock | |
| Solventum | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 3,564 | 3,564 | - | - | Restricted Stock Units | |
| Solventum | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 1,980 | 5,544 | - | - | Restricted Stock Units | |
| Baxter International | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 5,952 | 23,876 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Hologic | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 4,536 | 4,536 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 1,572 | 20,730 (0%) | 0% | - | Common Stock | |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 6,459 | 70,342 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 6,459 | 0 | - | - | Restricted Stock Units | |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.22 per share. | 12 May 2023 | 25,000 | 60,133 (0%) | 0% | 9.2 | 230,500 | Common Stock |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2023 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.22 per share. | 12 May 2023 | 3,750 | 63,883 (0%) | 0% | 9.2 | 34,575 | Common Stock |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2023 | 3,750 | 0 | - | - | Stock Option (right to buy) | |
| Baxter International | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 4,573 | 17,894 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Hologic | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 4,210 | 4,210 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 1,465 | 19,158 (0%) | 0% | - | Common Stock | |
| Axogen Inc | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 11,811 | 11,811 | - | - | Stock Option (right to purchase) | |
| Axogen Inc | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 6,459 | 6,459 | - | - | Restricted Stock Units | |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 3,036 | 35,133 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 3,036 | 0 | - | - | Restricted Stock Units | |
| Baxter International | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 13,168 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Hologic | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 5,293 | 5,293 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 1,565 | 17,693 (0%) | 0% | - | Common Stock | |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 6,173 | 32,097 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc | Amy A. Wendell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 6,173 | 0 | - | - | Restricted Stock Units | |
| Axogen Inc | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 6,030 | 6,030 | - | - | Stock Option (right to purchase) | |
| Axogen Inc | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 3,036 | 3,036 | - | - | Restricted Stock Units | |
| Baxter International | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 5,685 | 5,685 | - | - | Stock Option (Right to Buy) | |
| Baxter International | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 1,116 | 10,365 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Hologic | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 5,055 | 5,055 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Amy A. Wendell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 1,478 | 16,128 (0%) | 0% | - | Common Stock |